Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ST13P6 is a human pseudogene officially named "Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 6". It is also referenced as FAM10A6 or FAM10A6P[2][5][8][9][10]. As a pseudogene, it does not code for a functional protein and is not known to have established biological functions, disease associations, or roles as a therapeutic target. Pseudogenes typically arise from gene duplication or retrotransposition but are considered nonfunctional remnants, and there is no evidence that ST13P6 is actively transcribed or translates into a functional product[3][5][8][9]. The related functional gene is ST13, which encodes a protein involved in chaperone-mediated protein folding, but this does not apply to the pseudogene ST13P6[7][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 6 (ST13P6).